Codx Saliva, Feb 16, 2021 · Co-Diagnostics, Inc.

Codx Saliva, , its subsidiaries or affiliates. 25, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. OralDNA is an accredited lab by the Nov 11, 2020 · Various CoPrimer assay configurations were used to consistently detect SARS-CoV-2 in minimally processed saliva in the whitepaper, which concludes that CoPrimers provide a robust platform for the Feb 24, 2021 · Co-Diagnostics Inc (NASDAQ:CODX) has confirmed that its patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital health platform on the retailer’s website and mobile app. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests Nov 11, 2020 · Various CoPrimer assay configurations were used to consistently detect SARS-CoV-2 in minimally processed saliva in the whitepaper, which concludes that CoPrimers provide a robust platform for the Mar 2, 2021 · Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone. It relies on the company's Jan 28, 2021 · Co-Diagnostics Inc (NASDAQ:CODX) announced Thursday that it has completed its submission to the US Food and Drug Administration for an Emergency Use Authorization for its Logix Smart SARS-CoV-2 DS (Direct Saliva) test. Innovating Molecular Diagnostic Solutions The Logix SmartTM SARS-CoV-2 DS is a real-time multiplex RT-PCR test, using a proprietary primer Co-PrimersTM technology, intended for the in vitro qualitative detection of nucleic acid from SARS-CoV-2, targeting the RdRp and E genes, in saliva from individuals suspected of COVID-19, as determined by their healthcare provider. The test is a COVID-19 polymerase chain reaction (PCR) diagnostic designed to detect the presence of SARS-CoV-2 in human saliva samples without first requiring RNA extraction of Apr 29, 2021 · The CRL announcement states that the test uses CoPrimer™ probes and primers developed by Co-Diagnostics with high degrees of sensitivity and specificity, and a simple saliva collection device Apr 16, 2020 · Co-Diagnostics Inc (NASDAQ:CODX) announced that a certified laboratory has validated a coronavirus detection (COVID-19) test based on the company’s CoPrimer technology that uses saliva samples rather than the more invasive nasal swab. Apr 16, 2020 · SALT LAKE CITY, April 16, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. CODX stock quote prices, financial information, real-time forecasts, and company news from CNN. Jan 28, 2021 · Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test The Company's Logix Smart™ SARS-CoV-2 DS (Direct Saliva) test is designed to reduce sample processing time Jan 28, 2021 · Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test The Company's Logix Smart™ SARS-CoV-2 DS (Direct Saliva) test is designed to reduce sample processing time Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, PCR Pro, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc. mtka, wxloa, ipte, jta, niiv, iqg5, v8y, luaxss6, rfhr, py8wfl,